Clinical Trials
3 trialsNCT04294641 2026-01-23
Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT07062250 2025-07-14
HOME-BLOOD
Rigshospitalet, Denmark
Phase NA Recruiting
NCT03086252 2018-07-26
Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot Study
Emory University
Phase NA Withdrawn